Read this article about findings from the most recent Biopharma Confidence Index that show that the pandemic has substantially influenced biopharma executives’ expectations in key areas like artificial intelligence/machine learning and real-world evidence.

If your study is struggling to reinvent its tactics in the face of COVID-19, read this eBook to find out how to overcome challenges.

Use this infographic to learn how to get your neurodegenerative trial on solid ground with a constructive and practical evaluation of your operations and study execution tactics.

Watch Aman Khera, one of Worldwide’s Diversity & Inclusion champions, speak in TOPRA’s D&I webinar. Hear her story while also knowledge sharing about how to work cross-culturally in global teams

In this video, Aman Khera shares her personal journey into diversity & inclusion and explores why the D&I conversation is here to stay.

Founded by a team of neuroscientists, neuroscience is in the DNA of Worldwide Clinical Trials. Our dedicated Neuroscience Business Unit is made up of dedicated clinical research professionals uniquely committed to work in this specific therapeutic area. Read the latest fact sheet to learn more about the depth of experience that Worldwide has to offer.